Pivotal bioVenture Partners Investment Advisor LLC

CIK 0001844645 · Q2 2026

13F Equity AUM

$307.8M

+10.0% QoQ

Positions

0 QoQ

AUM Rank

#6,492

Top 52%

Skill Alpha (FF)

+39.8%/yr^ns

No Clear Edge

Rank #47 · Top 0.6%

vs S&P -1.1%/yr (unadj.)

Quarters Tracked

~5 years

Portfolio Concentration

Top 5: 66.9%Top 10: 95.1%Top 20: 100.0%

PCVX26.9%

ARQT10.8%

TRVI10.6%

AVALYN PHARMACEUTICALS INC10.3%

EVMN8.3%

MPLT7.1%

OCSAW6.8%

BIOA5.2%

IMNM5.0%

ZBIO4.0%

Others (3)4.9%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare82.9%

Unclassified17.1%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 13Median: 6.79%Avg: 7.69%

0–0.5%

0(0.0%)

0.5–1%

1(0.7%)

1–3%

2(4.2%)

3–5%

1(4.0%)

5%+

9(91.1%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 13vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New1Increased3Decreased4Exited1

New Positions

AVALYN PHARMACEUTICA…10.3%

+967K

Increased

TRVI10.6%

+189K(+12%)

AVTX2.6%

+138K(+47%)

PCVX26.9%

+53K(+4%)

Decreased

OCSAW6.8%

-174,033(-10%)

ZBIO4.0%

-101,225(-17%)

ARQT10.8%

-90,609(-7%)

MPLT7.1%

-1(0%)

Exited

BOLT

-42,581

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...